BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Tan PX, Huang W, Liu PP, Pan Y, Cui YH. Dynamic changes in the radiologic manifestation of a recurrent checkpoint inhibitor related pneumonitis in a non-small cell lung cancer patient: A case report. World J Clin Cases 2021; 9(30): 9108-9113 [PMID: 34786393 DOI: 10.12998/wjcc.v9.i30.9108]
URL: https://www.wjgnet.com/2307-8960/full/v9/i30/9108.htm
Number Citing Articles
1
Yu Zhou, Baozhen Ma, Tiepeng Li, Quanli Gao, Lingdi Zhao. Immune-related pneumonitis requiring low-dose prednisone maintenance in one patient with durable complete responseJournal of Oncology Pharmacy Practice 2023; 29(4): 986 doi: 10.1177/10781552221127699
2
DurvalumabReactions Weekly 2022; 1887(1): 291 doi: 10.1007/s40278-022-07956-z
3
Peixin Tan, Wei Huang, Xinyan He, Fengquan Lv, Yanhai Cui, Shasha Du. Risk Factors for Refractory Immune Checkpoint Inhibitor-related Pneumonitis in Patients With Lung CancerJournal of Immunotherapy 2023; 46(2): 64 doi: 10.1097/CJI.0000000000000451
4
Tang-Her Jaing, Yi-Lun Wang, Chia-Chi Chiu. Immune Checkpoint Inhibitors for Pediatric Cancers: Is It Still a Stalemate?Pharmaceuticals 2024; 17(8): 991 doi: 10.3390/ph17080991